Day 1 - Friday, 6 March
Meeting category
Date(s)
6 Mar 2020 - 7 Mar 2020
Location
Boston,
MA,
United States
EACCME
2
Organizer
Titanium Level Support
Sponsor logos
International Workshop on HIV & Women 2020
Related Enduring Materials
Enduring Materials
Opening of the Workshop - 8:30
8:30 EST
Opening Lecture
Session 1: Research in HIV and Women Over the Last Decade: Successes and Challenges - 8:55
Lorraine Sherr, PhD, MBE
8:55 EST
Antiretroviral Therapy, Women in Clinical Trials
9:10 EST
Prevention of Mother-to-Child Transmission
9:25 EST
Prevention Options for Women
9:40 EST
Comorbidities of Importance to Women
9:55 EST
Psychosocial issues for women living with HIV
Clinical and Health Psychology, Institute of Global Health, University College London (UCL), United Kingdom
10:10 EST
Involvement of Women Living with HIV in Research
Abstract-driven Presentations - 10:55
10:55 EST
Sex-specific analyses in oral abstracts from CROI 2019 #1
William Short, MD, MPH
University of Pennsylvania, USA
11:10 EST
Outcomes following prenatal exposure to Dolutegravir: the Dolomite - EPPICC Study #2
Claire Thorne, BA, MSc, PhD
University College London, UK
11:25 EST
Vitamin D status in pregnant women living with HIV in Denmark and association with birth outcomes - A nationwide cohort study
Ellen Moseholm, MScH, PhD
Copenhagen University Hospital, Hvidovre, Denmark
11:40 EST
Impact of Dolutegravir based ART among Indian women
Poongulali Selvamuthu, MD
CART CRS /Infectious Diseases Medical Center, India
11:55 EST
Discussion
12:40 EST
Meet-the-expert Lunch:
Table 1: Antiretroviral trials: Annette Haberl, Sharon Walmsley
Table 2: PrEP: Catherine Hankins, Sally Hodder
Table 3: Pregnancy and breastfeeding: Lynn Mofenson, Deborah Money, Natella Rakhmanina
Table 4: Aging women: Giovanni Guaraldi, Margaret Johnson
Table 5: Mental health: Mona Loutfy, Lorraine Sherr
Session 2: Debate: U=U does not apply to women - 13:40
13:40 EST
A Pro-Con Debate Involving Experts and Community Representatives
Abstract-Driven Presentations - 15:10
15:10 EST
Maternal and cord plasma bioactive eicosanoid profiles differ in pregnant women living with HIV compared to HIV - negative pregnant women #5
15:25 EST
Adolescent girls and young women: Should they be formally recognized as a key population for HIV? #6
Madlen Nash, MSc
AIDS-Free World, Canada
15:40 EST
Women on anti-retroviral therapy (ART) are less likely to achieve HIV RNA <50 copies/ml compared to men – Real World Data from the National Swedish InfCareHIV #7
Asa Mellgren, MD, PhD
Clinic Of Infectious Diseases, Sweden
15:55 EST
Not recommended, but done: Breastfeeding with HIV in Germany #8
Lila Haberl, MD
Hivcenter, University Hospital, Goethe University, Germany
Session 3: ART Research in Pregnant and Breastfeeding Women - 16:25
16:25 EST
Better, earlier pregnancy and lactation data for new HIV drugs: how do we get there
16:40 EST
Round Table Discussion
Welcome drinks, poster viewing session and guided poster tour 1 -
Women Race, Age and Regional US & Non-US Subgroup Analysis of Dolutegravir (DTG) and Non-integrase inhibitor treatment (non-INSTI) regimens in naïve randomized clinical trials at Week 48 #16
Romina Quercia
-
ATLAS and FLAIR: Efficacy, pharmacokinetics and reasons for satisfaction in women with Cabotegravir & Rilpivirine long-acting regimen at week 48 #17
Romina Quercia
-
Dolutegravir-containing ART does not reduce etonogestrel implant concentrations #18
Rena Patel
-
Cabotegravir: Assessment of reproductive and developmental toxicity in animal studies 1 #19
M.K. Ziejewski
-
Cabotegravir pharmacokinetic tail in pregnancy and neonatal outcomes #20
Parul Patel
-
Day 2 - Saturday, 7 March 2020
Session 4: 90:90:90: Which Women Are Being Left Behind? - 8:30
8:45 EST
Eastern Europe
9:00 EST
Africa
9:30 EST
India/Asia
Vidya Mave, MD
Bj Government Medical College, India
9:45 EST
Discussion
Guided poster tour 2: Pregnancy -
Achieving the third 95: Keeping adolescents living with HIV virally suppressed in rural Nigeria in test and treat era using Continuous Quality Improvement Model of Peer Counseling & Support Group #21
Saheed Usman
-
Timing of HIV diagnosis in HIV-positive pregnant women giving birth in a high prevalence Russian region #22
Rebecca Sconza
-
Mode of birth among women living with HIV: A population-based retrospective cohort study #23
Esther Shoemaker
-
Prevalence of polypharmacy and medication use contraindicated during pregnancy among a cohort of women living with HIV who are of childbearing age, 2016-2017 #24
William Short
-
Clinical trial simulation to improve HIV pre-exposure prophylaxis dosing in pregnancy #25
Rachel Scott
-
Guided poster tour 2: HIV transmission and progression -
Social media influence on the sexual behaviours of undergraduate students of the university of Buea, Cameroon #26
Ikome Theckla Efeti
-
Why does sex make a difference in HIV clinical course? A bioinformatics analysis of differential expressed gene in male and female with HIV disease #27
Kulachanya Suwanwongse
-
HIV transmission patterns among people who inject drugs in the United States #28
Samira Sami
-
Disparities in PrEP uptake and adherence: implementation of routine adherence monitoring in Philadelphia PrEP clinic #29
Elijah Kahn-Woods
-
HIV/AIDS Prevention Interventions for Black Women in the U.S.: A Systematic Review #30
Amber Sophus
-
Session 5: Abstract-Driven Presentations - 11:15
11:15 EST
Determinants of PrEP initiation in women at high risk for HIV #9
Rachel Scott, MD, MPH
Medstar Washington Hospital Center, USA
11:30 EST
Validating incident pregnancies among women using contraceptives and antiretrovirals #10
Rena Patel, MD
University of Washington, USA
11:45 EST
Post-Exposure Prophylaxis in Victims of Sexual Violence: Experience at the Condesa Specialized Clinic (CSC) #11
Teresita Cabrera, MD
Clínica Especializada Condesa, Mexico
12:00 EST
Examining differences in syndemic factors by gender and sexual orientation among women, straight men, and gay, bisexual, and other men who have sex with men #12
Kalysha Closson, MSc
University of British Columbia, Canada
12:15 EST
Discussion
Session 6: Women Surviving and Aging with HIV - 13:30
13:30 EST
WIHS Cohort
14:00 EST
Modena Cohort
Abstract-Driven Presentations - 14:45
14:45 EST
CD4:CD8 ratio normalization among treatment naive women #13
Alice Zhabokritsky, MD
University Of Toronto, Canada
15:00 EST
Differences by gender and sexual orientation in treatment satisfaction and aspirations among persons living with HIV #14
Chinyere Okoli, PharmD
ViiV Healthcare, UK
Attitudes towards health, sexual intimacy, and child-bearing among women living with HIV in 24 countries
Chinyere Okoli, PharmD
ViiV Healthcare, UK
Gender, equality, and empowered decision-making in HIV care
Chinyere Okoli, PharmD
ViiV Healthcare, UK
15:15 EST
Impact of Microbial Exposures on HPV Immune Titers and Infection Among HPV-Vaccinated Women Living with HIV #15
Elisabeth McClymont, MD
University of British Columbia, Canada
15:30 EST
Discussion
Overview
Welcome
We made history together!
We would like to thank all 116 participants of the 10th edition of the International Workshop on HIV & Women (6 - 7 March 2020, Boston, MA, USA) for their invaluable contribution in making this meeting such a success. The knowledge and life experiences shared in this workshop were incredibly valuable and will be cherished and put into good use.
We pride ourselves on being the only CROI-affiliated event that went ahead. Although the COVID-19 outbreak prevented some of our participants and presenters from attending in person, it made us think out of the box. In almost every session we had one or more speakers presenting remotely, and almost 20 participants were able to join us from home or their place of work.
On behalf of the Organizing Committee, we would also like to express our gratitude to ViiV Healthcare, Gilead and Janssen for their generous support.
We look forward to seeing you at the next edition of the meeting
Committees
Scientific Committee
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
- Karoline Aebi-Popp, MD, MSc, University Hospital Bern, Switzerland
- Marina Bobkova, MD, Ivanovsky Institute of Virology, Russia
- Dazon Dixon Diallo, MPH, Sister Love, United States
- Annette Haberl, MD, HIV CENTER University Hospital Frankfurt, Germany
- Shirin Heidari, PhD, Institute of International and Development Studies, United Kingdom
- Angela Kashuba, PharmD, IUNC, Chapel Hill, United States
- Miriam-Colette Kempf, MD, MPH, University of Alabama at Birmingham , United States
- Justyna Kowalska, MD, Hospital for Infectious Diseases, Poland
- Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
- Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
- Mariana Mardarescu, MD, PhD, Institute for Infectious Disease Matei Bals, Romania
- Deborah Money, MD, MSc, University of British Columbia, Canada
- Teresia Otieno, ICW North America, United States
- Shema Tariq, PhD, University College London, United Kingdom
- Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
- Markela Zanni, MD, MGH/Harvard Medical School, United States
Support
Endorsers
Media
Image
Language
Related Programs
